$2.48
-0.01-0.40%
At close: -
$2.36
-0.12-4.84%
After Hours: Apr 17, 4:50 PM EDT
Comments
Loading...
Telomir Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:TELO | Benzinga
Telomir Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Telomir Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Telomir Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Telomir Pharmaceuticals (TELO) stock?
There is no price target for Telomir Pharmaceuticals
What is the most recent analyst rating for Telomir Pharmaceuticals (TELO)?
There is no analyst for Telomir Pharmaceuticals
When was the last upgrade for Telomir Pharmaceuticals (TELO)?
There is no last upgrade for Telomir Pharmaceuticals
When was the last downgrade for Telomir Pharmaceuticals (TELO)?
There is no last downgrade for Telomir Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Telomir Pharmaceuticals (TELO)?
There is no next analyst rating for Telomir Pharmaceuticals.
Is the Analyst Rating Telomir Pharmaceuticals (TELO) correct?
There is no next analyst rating for Telomir Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
